Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Biotech
Harmony's pivotal trial flops as placebo response causes discord
Two years after picking up ZYN002 despite a midphase flop, the biotech has reported that a registrational trial missed its primary endpoint.
Nick Paul Taylor
Sep 24, 2025 9:35am
Sanofi's R&D chief 'pretty pragmatic' about clinical setbacks
Sep 17, 2025 8:01am
aTyr flunks phase 3 lung disease trial, deflating stock
Sep 15, 2025 9:56am
Roche sees Alnylam RNAi drug flunk trial, still plans phase 3
Sep 1, 2025 4:39am
Celldex ends esophageal program despite hitting primary endpoint
Aug 20, 2025 6:42am
Pfizer's SCD drug fails ph. 3 study in latest blow to GBT legacy
Aug 18, 2025 7:31am
